Graphics credits: COMPARTMENTS | More Info
| Parameter | Value |
|---|---|
| Gene | MAP3K8 |
| Protein Name | M3K8_HUMAN |
| Organism | Homo sapiens (Human) |
| Alternative name(s) | Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25) (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2) (TPL-2) |
| Protein Family | Protein kinase superfamily |
| NCBI Gene ID | 1326 |
| UniProt ID | P41279 |
| Enzyme Class | 2.7.11.25 |
| Molecular Weight | 52925 |
| Protein Length | 467 |
| Protein Domain | InterPro | Pfam |
| 3D Structure |
PDBe |
PDBj |
RCSB PDB |
DrugPort
ModBase | SwissModel |
| Gene Expression | Gene Expression Atlas |
| Function and Disease | OMIM |
| Protein-protein Interaction Database | STRING | IntAct | MINT |
| Kinase Database | Phospho.ELM | PhosphoSite | NetworKIN |
| Catalytic Activity (UniProt annotation) | ATP + a protein = ADP + a phosphoprotein. |
| Localization | Cytoplasm |
| Function (UniProt annotation) | Required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant. |
| Gene Ontology | GO:0000287; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0023014; GO:0031098; GO:0031295; GO:0032147; GO:0051403; GO:0070498 |
| Gene Name | Organism | P-Site | Sequence(+/-7) | Conservation | Disorder | Curator Assessment | Reliability | Evidence Class | Evidence Logic | PubMed | Phospho-ELM | PhosphoSite-Plus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIM2 (Q9P1W9) | Homo sapiens | S400 | EDQPRCQSLDSALLE | 0.873 | 0.6576 | - | - | - | - | - | - |
|
| PIM2 (Q9P1W9) | Homo sapiens | S413 | LERKRLLSRKELELP | 0.038 | 0.3704 | - | - | - | - | - | - |
|
Reactome Pathways
No KEGG pathways found
No NCI Nature pathways found